Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Net Margin (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Net Margin for 15 consecutive years, with 118.78% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Margin fell 11867.0% year-over-year to 118.78%, compared with a TTM value of 37.42% through Sep 2025, down 3023.0%, and an annual FY2024 reading of 11.33%, down 450.0% over the prior year.
  • Net Margin was 118.78% for Q3 2025 at Sanara MedTech, down from 7.06% in the prior quarter.
  • Across five years, Net Margin topped out at 19.51% in Q3 2022 and bottomed at 118.78% in Q3 2025.
  • Average Net Margin over 5 years is 21.63%, with a median of 14.48% recorded in 2025.
  • The sharpest move saw Net Margin surged 5420bps in 2022, then tumbled -11867bps in 2025.
  • Year by year, Net Margin stood at 50.45% in 2021, then skyrocketed by 46bps to 27.48% in 2022, then soared by 95bps to 1.48% in 2023, then crashed by -326bps to 6.33% in 2024, then plummeted by -1778bps to 118.78% in 2025.
  • Business Quant data shows Net Margin for SMTI at 118.78% in Q3 2025, 7.06% in Q2 2025, and 14.48% in Q1 2025.